Anti-blepharitis Cosmetic Composition with Verbascoside and Oligopeptide
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cosmetic compositions exacerbate or fail to address the symptoms of blepharitis, an inflammatory eyelid disorder characterized by bacterial colonization and immune-mediated inflammatory damage, leading to discomfort and potential corneal issues.
Innovation Solution
Formulations containing verbascoside, oligopeptide-10, and sulfonated shale oil, applied topically in specific concentrations, which provide anti-bacterial and anti-inflammatory properties, effectively preventing and treating blepharitis while maintaining cosmetic appearance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional cosmetic compositions are used to maintain cosmetic appearance, then aesthetic function is maintained, but blepharitis symptoms are exacerbated or not addressed
Solution Approach 1:
The patent changes the chemical composition parameters of cosmetic formulations by incorporating specific active ingredients (verbascoside, oligopeptide-10, sulfonated shale oil) at defined concentrations. These parameter changes transform conventional cosmetics into therapeutic compositions that actively treat blepharitis rather than merely providing cosmetic coverage, thereby resolving the contradiction between maintaining appearance and avoiding symptom exacerbation
Solution Approach 2:
The patent creates composite cosmetic formulations by combining multiple active ingredients (verbascoside, oligopeptide-10, sulfonated shale oil) with cosmetic base materials. This composite approach enables the composition to simultaneously provide cosmetic functionality and therapeutic anti-inflammatory/anti-bacterial effects, resolving the contradiction by integrating both functions into a single formulation
2Ease of manufacture
If heavy cosmetics are worn to maintain desired appearance, then cosmetic coverage is improved, but blepharitis symptoms are worsened
Solution Approach 1:
The patent converts potentially harmful cosmetic ingredients into beneficial therapeutic agents by selecting specific ingredients with proven anti-inflammatory and anti-bacterial properties. The formulation transforms the act of applying cosmetics (which traditionally exacerbates blepharitis) into a therapeutic intervention that treats the condition while maintaining cosmetic appearance, thereby converting harm into benefit
3Reliability
If topical treatments are applied to treat blepharitis, then anti-inflammatory and anti-bacterial effects are achieved, but cosmetic appearance may be compromised
Solution Approach 1:
The patent creates a multi-functional composition that simultaneously provides cosmetic coverage, anti-inflammatory treatment, and anti-bacterial protection. This universal formulation eliminates the need for separate therapeutic and cosmetic products, allowing users to achieve both therapeutic effectiveness and cosmetic appearance with a single application, thereby resolving the contradiction between treatment efficacy and cosmetic safety
Data Source
AI summary
Compositions and methods for the prevention and treatment of blepharitis, where the compositions include verbascoside, oligopeptide-10, and sulfonated shale oil, and the preparation of such compositions.